Transplantation of induced bone marrow mesenchymal stem cells improves the cardiac function of rabbits with dilated cardiomyopathy via upregulation of vascular endothelial growth factor and its receptors

Experimental Biology and Medicine

Volumn 236, Issue 9, 2011, Pages 1100-1107

  Mu, Yuming ^a   Cao, Guiqiu ^a   Zeng, Qianqian ^a   Li, Yanhong ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells; Cardiomyopathy; Collagen fibers; Vascular endothelial growth factor

Indexed keywords

AZACITIDINE; COLLAGEN FIBER; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONGESTIVE CARDIOMYOPATHY; CONTROL GROUP; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ANIMALS; AZACITIDINE; BLOOD PRESSURE; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RABBITS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ORYCTOLAGUS CUNICULUS;

EID: 80052504028     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011066     Document Type: Article

References (29)

1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
2. Kajstura J, Leri A, Finato N, Di C, Beltrami CA, Anversa P. Myote proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95:8801-5.
3. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardium infaction in rats. Circ Res 1991;68:856-9.
4. Chiu RCJ, Zibaitis A, Kao RI. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8.
5. Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med (Maywood) 2001;231:39-49.
6. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Bio Med (Maywood) 2001;226:507-20.
7. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stroma cells for cellular cardiomyopathy: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000;120:999-6.
8. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chrinic experimrntal myocardial ischemia. J Am Coll Cardiol 2001;37:1726-32.
9. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, Esato K. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 2000;89:189-95.
10. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M, Tokudome T, Mori H, Miyatake K, Kitamura S. Transplantation of mysenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-35.
11. Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005;112:1813-24.
12. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhance collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-52.
13. Siveski-Hiskovic N, Hill M, Chow DA, Singal PK. Probocol protests against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995;91:10-5.
14. Wang B, Wang G, Ba X, Song J-D. Bone marrow mesenchymal stem cells can be induced to differentiate into cardiomyocytes-like in vitro. Chin J Cell Biol 2005;27:211-4.
15. Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV, Wobus AM. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002;91:189-201.
16. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-05.
17. Mollmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M, Schaper J, Hamm CW, Elsässer A. Bone marrow-derived cells contribute to infarct remodeling. Cardiovasc Res 2006;71:661-71.
18. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21.
19. Oric D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
20. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002;90:634-40.
21. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarcted model: engraftment and functional effects. Ann Thorac Surg 2002;73:1919-25.
22. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cell derived from adult marrow. Nature 2002;418:41-9.
23. Rangappa S, Entwistle JW, Wechsler AS, Kresh JY. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 2003;126:124-32.
24. Sperr WR, Bankl HC, Mundigler Q, Klappacher G, Grossschmidt K, Agis H, Simon P, Laufer P, Imhof M, Radaszkiewicz T, Glogar D, Lechner K, Valent P. The human mast cell: localization, isolation, phenotype and functional characterization. Blood 1994;84:3876-84.
25. Deten A, Volz HC, Briest W, Zimmer HG. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction: experimental studies in rats. Cardiovasc Res 2002;55:329-40.
26. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002;91:1092-9.
27. We GC, Siroi MG, Qu R, Liu P, Roulea JL. Effect of quinapril on myocardial function, ventricular remodeling and cardial cytokine expression in congestive heart failure in the rat. Cardiovasc Drugs Ther 2002;16:29-36.
28. Bauer EP, Kuki S, Arras M, Zimmerman R, Schaper W. Increased growth factor transcription after pulmonary artery banding. Eur J Cardiothorac Surg 1997;11:818-23.
29. Factor SM, Robinson TF. Comparative connective tissue structure-function relationships in biologic pumps. Lab Invest 1988;58:150-6.